Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications

References

• Younossi Z, Stepanova M, Ong JP, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17(4):748–755.e3. doi:10.1016/j.cgh.2018.05.057
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604. doi:10.1038/s41575-019-0186-y
   PubMed Web of Science ®Google Scholar
• Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308–319. doi:10.1016/j.gendis.2020.01.014
   PubMed Web of Science ®Google Scholar
• Zhou F, Shang W, Yu X, et al. Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment. Med Res Rev. 2018;38(2):741–767. doi:10.1002/med.21455
   PubMed Web of Science ®Google Scholar
• Li Y, Li P-P, Sun D-P, et al. One- versus two-stage partial hepatectomy for large resectable solitary hepatocellular carcinomas determined preoperatively to have a narrow resection margin: a propensity score matching analysis. Hepatobiliary Surg Nutr. 2022;11(5):662–674. doi:10.21037/hbsn-20-711
   PubMedGoogle Scholar
• Liu G, Wang K, Kuang S, et al. The natural compound GL22, isolated from Ganoderma mushrooms, suppresses tumor growth by altering lipid metabolism and triggering cell death. Cell Death Dis. 2018;9(6):689. doi:10.1038/s41419-018-0731-6
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang Y, Zhang Y, et al. Correction to: the function and mechanisms of action of circular RNAs in Urologic Cancer. Mol Cancer. 2023;22(1):73. doi:10.1186/s12943-023-01774-2
   PubMed Web of Science ®Google Scholar
• Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852–3856. doi:10.1073/pnas.73.11.3852
   PubMed Web of Science ®Google Scholar
• Capel B, Swain A, Nicolis S, et al. Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell. 1993;73(5):1019–1030. doi:10.1016/0092-8674(93)90279-Y
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi:10.1038/nature11928
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang Y, Deng L, et al. The function and regulation network mechanism of circRNA in liver diseases. Can Cell Inter. 2022;22(1):141. doi:10.1186/s12935-022-02559-1
   PubMed Web of Science ®Google Scholar
• Du A, Li S, Zhou Y, et al. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer. 2022;21(1):109. doi:10.1186/s12943-022-01575-z
   PubMed Web of Science ®Google Scholar
• Affo S, Yu L, Schwabe RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer. Ann Rev Pathol. 2017;12(1):153–186. doi:10.1146/annurev-pathol-052016-100322
   PubMedGoogle Scholar
• Wu Z, Yu X, Zhang S, et al. Mechanism underlying circRNA dysregulation in the TME of digestive system cancer. Front Immunol. 2022;13:951561. doi:10.3389/fimmu.2022.951561
   PubMed Web of Science ®Google Scholar
• Shen H, Liu B, Xu J, et al. Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer. J Hematol Oncol. 2021;14(1):134. doi:10.1186/s13045-021-01145-8
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-7
   PubMed Web of Science ®Google Scholar
• Schmidt CA, Matera AG. tRNA introns: presence, processing, and purpose. Wiley interdisciplinary reviews. RNA. 2020;11(3):e1583. doi:10.1002/wrna.1583
   PubMed Web of Science ®Google Scholar
• Yang L, Wilusz JE, Chen L. Biogenesis and regulatory roles of circular RNAs. Annu Rev Cell Dev Biol. 2022;38(1):263–289. doi:10.1146/annurev-cellbio-120420-125117
   PubMedGoogle Scholar
• Chen L. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–490. doi:10.1038/s41580-020-0243-y
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–157. doi:10.1261/rna.035667.112
   PubMed Web of Science ®Google Scholar
• Qu L, Yi Z, Shen Y, et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell. 2022;185(10):1728–1744.e16. doi:10.1016/j.cell.2022.03.044
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Y, Zhou S, et al. Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. J Control Release. 2022;348:84–94. doi:10.1016/j.jconrel.2022.05.043
   PubMed Web of Science ®Google Scholar
• Huang C, Liang D, Tatomer DC, et al. A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs. Genes Dev. 2018;32(9–10):639–644. doi:10.1101/gad.314856.118
   PubMed Web of Science ®Google Scholar
• Pan Z, Zhao R, Li B, et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol Cancer. 2022;21(1):16. doi:10.1186/s12943-021-01485-6
   PubMed Web of Science ®Google Scholar
• Ren L, Jiang Q, Mo L, et al. Mechanisms of circular RNA degradation. Commun Biol. 2022;5(1):1355. doi:10.1038/s42003-022-04262-3
   PubMed Web of Science ®Google Scholar
• Hammond SM, Boettcher S, Caudy AA, et al. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science. 2001;293(5532):1146–1150. doi:10.1126/science.1064023
   PubMed Web of Science ®Google Scholar
• Park OH, Ha H, Lee Y, et al. Endoribonucleolytic Cleavage of m6A-Containing RNAs by RNase P/MRP Complex. Molecular Cell. 2019;74(3):494–507.e8. doi:10.1016/j.molcel.2019.02.034
   PubMed Web of Science ®Google Scholar
• Fischer JW, Busa VF, Shao Y, et al. Structure-mediated RNA Decay by UPF1 and G3BP1. Molecular Cell. 2020;78(1):70–84.e6. doi:10.1016/j.molcel.2020.01.021
   PubMed Web of Science ®Google Scholar
• Zhang H, Deng T, Ge S, et al. Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7. Oncogene. 2019;38(15):2844–2859. doi:10.1038/s41388-018-0619-z
   PubMed Web of Science ®Google Scholar
• Qin S, Mao Y, Chen X, et al. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma. Int J Biol Sci. 2021;17(12):3059–3079. doi:10.7150/ijbs.62767
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283. doi:10.1038/nrg.2016.20
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.014
   PubMed Web of Science ®Google Scholar
• Yao Z, Xu R, Yuan L, et al. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death Dis. 2019;10(12):945. doi:10.1038/s41419-019-2176-y
   PubMed Web of Science ®Google Scholar
• Dummer R, Schadendorf D, Ascierto PA, et al. Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, Phase 3 trial. Lancet Oncol. 2017;18(4):435–445. doi:10.1016/S1470-2045(17)30180-8
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang Y, Zhang S, et al. circRNA circARNT2 suppressed the sensitivity of hepatocellular carcinoma cells to cisplatin by targeting the miR-155-5p/PDK1 axis. Mol Ther Nucleic Acids. 2021;23:244–254. doi:10.1016/j.omtn.2020.08.037
   PubMedGoogle Scholar
• Luo Z, Lu L, Tang Q, et al. CircCAMSAP1 promotes hepatocellular carcinoma progression through miR‐1294/GRAMD1A pathway. J Cell & Mol Med. 2021;25(8):3793–3802. doi:10.1111/jcmm.16254
   PubMed Web of Science ®Google Scholar
• Liu W, zheng L, Zhang R, et al. Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma. Mol Cancer. 2022;21(1):72. doi:10.1186/s12943-022-01529-5
   PubMed Web of Science ®Google Scholar
• Huang G, Liang M, Liu H, et al. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/beta-catenin pathway. Cell Death Dis. 2020;11(12):1065. doi:10.1038/s41419-020-03276-1
   PubMed Web of Science ®Google Scholar
• Huang X-Y, Zhang P-F, Wei C-Y, et al. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Mol Cancer. 2020;19(1):92. doi:10.1186/s12943-020-01213-6
   PubMed Web of Science ®Google Scholar
• Shi N, Shan B, Gu B, et al. Circular RNA circ-PRKCI functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-3680-3p in esophageal squamous cell carcinoma. J Cell Biochem. 2019;120(6):10021–10030. doi:10.1002/jcb.28285
   PubMed Web of Science ®Google Scholar
• Xu G, Zhang P, Liang H, et al. Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma. Cancer Cell Int. 2021;21(1):212. doi:10.1186/s12935-021-01902-2
   PubMed Web of Science ®Google Scholar
• Luo Y-Y, Tao K-G, Lu Y-T, et al. Hsa_Circ_0098181 suppresses hepatocellular carcinoma by sponging miR-18a-3p and targeting PPARA. Front Pharmacol. 2022;13:819735. doi:10.3389/fphar.2022.819735
   PubMed Web of Science ®Google Scholar
• Li L, He K, Chen S, et al. Circ_0001175 promotes hepatocellular carcinoma cell proliferation and metastasis by regulating miR-130a-5p. Onco Targets Ther. 2020;13:13315–13327. doi:10.2147/OTT.S262408
   PubMed Web of Science ®Google Scholar
• Fan W, Chen L, Wu X, et al. Circ_0031242 silencing mitigates the progression and drug resistance in DDP-resistant hepatoma cells by the miR-924/POU3F2 Axis. Cancer Manag Res. 2021;13:743–755. doi:10.2147/CMAR.S272851
   PubMed Web of Science ®Google Scholar
• Gu X, Zhang J, Ran Y, et al. Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression. Cell Death Dis. 2021;12(4):356. doi:10.1038/s41419-021-03626-7
   PubMed Web of Science ®Google Scholar
• Wu A, Li Y, Kong M, et al. Upregulated hsa_circ_0005785 facilitates cell growth and metastasis of hepatocellular carcinoma through the miR-578/April axis. Front Oncol. 2020;10:1388. doi:10.3389/fonc.2020.01388
   PubMed Web of Science ®Google Scholar
• Cai H, Hu B, Ji L, et al. Hsa_circ_0103809 promotes cell proliferation and inhibits apoptosis in hepatocellular carcinoma by targeting miR-490-5p/SOX2 signaling pathway. Am J Transl Res. 2018;10(6):1690–1702.
   PubMed Web of Science ®Google Scholar
• Bai K, Ma Y, Li J. Circular RNA circ_0001955 promotes hepatocellular carcinoma tumorigenesis by up-regulating alkaline ceramidase 3 expression through microRNA-655-3p. Bioengineered. 2022;13(2):2099–2113. doi:10.1080/21655979.2021.2023797
   PubMed Web of Science ®Google Scholar
• Su Y, Xu C, Liu Y, et al. Circular RNA hsa_circ_0001649 inhibits hepatocellular carcinoma progression via multiple miRNAs sponge. Aging. 2019;11(10):3362–3375. doi:10.18632/aging.101988
   PubMedGoogle Scholar
• Zhu Q, Lu G, Luo Z, et al. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/beta-catenin axis. Biochem Biophys Res Commun. 2018;497(2):626–632. doi:10.1016/j.bbrc.2018.02.119
   PubMed Web of Science ®Google Scholar
• Ding B, Fan W, Lou W. hsa_circ_0001955 enhances in vitro proliferation, migration, and invasion of HCC cells through miR-145-5p/NRAS axis. Mol Ther Nucleic Acids. 2020;22:445–455. doi:10.1016/j.omtn.2020.09.007
   PubMedGoogle Scholar
• Liu L, Gu M, Ma J, et al. CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma. Mol Cancer. 2022;21(1):149. doi:10.1186/s12943-022-01619-4
   PubMed Web of Science ®Google Scholar
• Dong ZR, Ke A-W, Li T, et al. CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity. Mol Cancer. 2021;20(1):75. doi:10.1186/s12943-021-01361-3
   PubMed Web of Science ®Google Scholar
• Yang G, Xu Q, Wan Y, et al. Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation. Cell. Signalling. 2021;86:110065. doi:10.1016/j.cellsig.2021.110065
   PubMed Web of Science ®Google Scholar
• Wu M, Sun T, Xing L. Circ_0004913 inhibits cell growth, metastasis, and glycolysis by absorbing miR-184 to regulate HAMP in hepatocellular carcinoma. Cancer Biother Radiopharm. 2020;38(10):708–719. doi:10.1089/cbr.2020.3779
   PubMedGoogle Scholar
• Guo X, Wang Z, Deng X, et al. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184. Cell Cycle. 2022;21(15):1557–1577. doi:10.1080/15384101.2022.2057633
   PubMed Web of Science ®Google Scholar
• Ma H, Huang C, Huang Q, et al. Circular RNA circ_0014717 suppresses hepatocellular carcinoma tumorigenesis through regulating miR-668-3p/BTG2 axis. Front Oncol. 2020;10:592884. doi:10.3389/fonc.2020.592884
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang J, Li P, et al. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3. Cell Death Dis. 2022;13(1):32. doi:10.1038/s41419-021-04345-9
   PubMed Web of Science ®Google Scholar
• Li M, Yue W, Li Q, et al. Circular RNA Circ_0000098 elevates ALX4 expression via adsorbing miR-1204 to inhibit the progression of hepatocellular carcinoma. Front Oncol. 2021;11:696078. doi:10.3389/fonc.2021.696078
   PubMedGoogle Scholar
• Xu L, Feng X, Hao X, et al. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019;38(1):98. doi:10.1186/s13046-019-1041-2
   PubMed Web of Science ®Google Scholar
• Fan X, Yang Y, Chen C, et al. Pervasive translation of circular RNAs driven by short IRES-like elements. Nat Commun. 2022;13(1):3751. doi:10.1038/s41467-022-31327-y
   PubMed Web of Science ®Google Scholar
• Liang WC, Wong C-W, Liang -P-P, et al. Translation of the circular RNA circbeta-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol. 2019;20(1):84. doi:10.1186/s13059-019-1685-4
   PubMed Web of Science ®Google Scholar
• Zhou W, Cai Z-R, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172. doi:10.1186/s12943-020-01286-3
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhou Q, Li X. Protein bait hypothesis: circRNA-encoded proteins competitively inhibit cognate functional isoforms. Trends Genet. 2021;37(7):616–624. doi:10.1016/j.tig.2021.04.002
   PubMed Web of Science ®Google Scholar
• Du WW, Zhang C, Yang W, et al. Identifying and characterizing circRNA-protein interaction. Theranostics. 2017;7(17):4183–4191. doi:10.7150/thno.21299
   PubMed Web of Science ®Google Scholar
• Sun S, Gao J, Zhou S, et al. A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling. J Exp Clin Cancer Res. 2020;39(1):252. doi:10.1186/s13046-020-01779-5
   PubMed Web of Science ®Google Scholar
• Hao X, Zhang Y, Shi X, et al. CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3zeta. J Exp Clin Cancer Res. 2022;41(1):281. doi:10.1186/s13046-022-02494-z
   PubMed Web of Science ®Google Scholar
• Gu Y, Wang Y, He L, et al. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling. Mol Cancer. 2021;20(1):132. doi:10.1186/s12943-021-01435-2
   PubMed Web of Science ®Google Scholar
• Yu T, Ran L, Zhao H, et al. Circular RNA circ-TNPO3 suppresses metastasis of GC by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL. Mol Ther Nucleic Acids. 2021;26:649–664. doi:10.1016/j.omtn.2021.08.029
   PubMedGoogle Scholar
• Wang Y, Gao R, Li J, et al. Downregulation of hsa_circ_0074854 suppresses the migration and invasion in hepatocellular carcinoma via interacting with HuR and via suppressing exosomes-mediated macrophage M2 polarization. Int J Nanomed. 2021;16:2803–2818. doi:10.2147/IJN.S284560
   PubMed Web of Science ®Google Scholar
• Chen M, Wong CM. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer. 2020;19(1):44. doi:10.1186/s12943-020-01172-y
   PubMed Web of Science ®Google Scholar
• Zhang L, Hou C, Chen C, et al. The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs. Mol Cancer. 2020;19(1):1–105. doi:10.1186/s12943-020-01224-3
   PubMed Web of Science ®Google Scholar
• Chen Y, Ling Z, Cai X, et al. Activation of YAP1 by N6-methyladenosine-modified circCPSF6 Drives MALIGNANCY IN HEPATOCELLULAR CARCINOMA. Cancer Res. 2022;82(4):599–614. doi:10.1158/0008-5472.CAN-21-1628
   PubMed Web of Science ®Google Scholar
• Wesselhoeft RA, Kowalski PS, Parker-Hale FC, et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Molecular Cell. 2019;74(3):508–520.e4. doi:10.1016/j.molcel.2019.02.015
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu Y, Qian Z, et al. circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma. Cell Death Dis. 2018;9(11):1091. doi:10.1038/s41419-018-1132-6
   PubMed Web of Science ®Google Scholar
• Duan JL, Chen W, Xie -J-J, et al. A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Mol Cancer. 2022;21(1):93. doi:10.1186/s12943-022-01537-5
   PubMed Web of Science ®Google Scholar
• Wang C, Liu W-R, Tan S, et al. Characterization of distinct circular RNA signatures in solid tumors. Mol Cancer. 2022;21(1):63. doi:10.1186/s12943-022-01546-4
   PubMed Web of Science ®Google Scholar
• Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93–115. doi:10.1038/nrc.2016.138
   PubMed Web of Science ®Google Scholar
• Liu B, Yang G, Wang X, et al. CircBACH1 (hsa_circ_0061395) promotes hepatocellular carcinoma growth by regulating p27 repression via HuR. J Cell Physiol. 2020;235(10):6929–6941. doi:10.1002/jcp.29589
   PubMed Web of Science ®Google Scholar
• Huang T, Song X, Xu D, et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10(19):8721–8743. doi:10.7150/thno.41648
   PubMed Web of Science ®Google Scholar
• Chen Z, Lu T, Huang L, et al. Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF. J Clin Invest. 2021;131(19). doi:10.1172/JCI148020
   Web of Science ®Google Scholar
• Liu X, Yang L, Jiang D, et al. Circ-DENND4C up-regulatesTCF4 expression to modulate hepatocellular carcinoma cell proliferation and apoptosis via activating Wnt/beta-catenin signal pathway. Cancer Cell Int. 2020;20(1):295. doi:10.1186/s12935-020-01346-0
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduc Target Ther. 2022;7(1):3. doi:10.1038/s41392-021-00762-6
   PubMed Web of Science ®Google Scholar
• Zhang B, Li F, Zhu Z, et al. CircRNA CDR1as/miR-1287/Raf1 axis modulates hepatocellular carcinoma progression through MEK/ERK pathway. Cancer Manage Res. 2020;12:8951–8964. doi:10.2147/CMAR.S252679
   PubMed Web of Science ®Google Scholar
• Frau M, Feo F, Pascale RM. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. J Hepatol. 2013;59(4):830–841. doi:10.1016/j.jhep.2013.04.031
   PubMed Web of Science ®Google Scholar
• Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–226. doi:10.1016/j.tcb.2018.12.001
   PubMed Web of Science ®Google Scholar
• Giannelli G, Koudelkova P, Dituri F, et al. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65(4):798–808. doi:10.1016/j.jhep.2016.05.007
   PubMed Web of Science ®Google Scholar
• Liu Y, Song J, Zhang H, et al. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway. J Exp Clin Cancer Res. 2022;41(1):164. doi:10.1186/s13046-022-02378-2
   PubMed Web of Science ®Google Scholar
• Meng J, Chen S, Han J-X, et al. Twist1 regulates vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma. Cancer Res. 2018;78(15):4150–4162. doi:10.1158/0008-5472.CAN-17-3009
   PubMed Web of Science ®Google Scholar
• Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741–4751. doi:10.1038/onc.2010.215
   PubMed Web of Science ®Google Scholar
• Wang M, Yang Y, Yang J, et al. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m(6)A-YTHDF3-Zeb1. Life Sci. 2020;257:118082. doi:10.1016/j.lfs.2020.118082
   PubMed Web of Science ®Google Scholar
• Qin L, Tang Z. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol. 2002;8(2):193–199. doi:10.3748/wjg.v8.i2.193
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang M, Zheng X, et al. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143(1):17–27. doi:10.1007/s00432-016-2256-7
   PubMed Web of Science ®Google Scholar
• Zhang Z. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. HPB. 2016;18:e313. doi:10.1016/j.hpb.2016.02.807
   Google Scholar
• Song LN, Qiao G-L, Yu J, et al. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1. J Exp Clin Cancer Res. 2020;39(1):114. doi:10.1186/s13046-020-01576-0
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhou L, Lv D, et al. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression. J Hematol Oncol. 2019;12(1):53. doi:10.1186/s13045-019-0739-0
   PubMedGoogle Scholar
• Ji Y, Yang S, Yan X, et al. CircCRIM1 promotes hepatocellular carcinoma proliferation and angiogenesis by sponging miR-378a-3p and regulating SKP2 expression. Front Cell Dev Biol. 2021;9:796686. doi:10.3389/fcell.2021.796686
   PubMed Web of Science ®Google Scholar
• Song P, Wang S, He C, et al. AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells. Circ Res. 2011;109(11):1230–1239. doi:10.1161/CIRCRESAHA.111.250423
   PubMed Web of Science ®Google Scholar
• Kurebayashi Y, Matsuda K, Ueno A, et al. Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironments. Hepatology. 2022;75(5):1139–1153. doi:10.1002/hep.32201
   PubMed Web of Science ®Google Scholar
• Huang XY, Huang Z-L, Huang J, et al. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res. 2020;39(1):20. doi:10.1186/s13046-020-1529-9
   PubMed Web of Science ®Google Scholar
• Li P, Song R, Yin F, et al. circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma. Mol Ther. 2022;30(1):431–447. doi:10.1016/j.ymthe.2021.08.027
   PubMed Web of Science ®Google Scholar
• Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391(10126):1163–1173. doi:10.1016/S0140-6736(18)30207-1
   PubMed Web of Science ®Google Scholar
• Chuah S, Lee J, Song Y, et al. Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma. J Hepatol. 2022;77(3):683–694. doi:10.1016/j.jhep.2022.03.039
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37(2):429–442. doi:10.1053/jhep.2003.50047
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tang W, Zhuo H, et al. Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-kappaB) pathway. Bioengineered. 2022;13(3):4786–4797. doi:10.1080/21655979.2022.2032972
   PubMed Web of Science ®Google Scholar
• Xu J, Ji L, Liang Y, et al. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther. 2020;5(1):298. doi:10.1038/s41392-020-00375-5
   PubMed Web of Science ®Google Scholar
• Liu M, Zhou J, Liu X, et al. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma. Gut. 2020;69(2):365–379. doi:10.1136/gutjnl-2018-317257
   PubMed Web of Science ®Google Scholar
• Liu L, Liao R, Wu Z, et al. Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474-3P-ALOX-15 and EMT axes. Biosci Trends. 2022;16(4):267–281. doi:10.5582/bst.2022.01281
   PubMed Web of Science ®Google Scholar
• Hao X, Sun G, Zhang Y, et al. Targeting immune cells in the tumor microenvironment of HCC: new opportunities and challenges. Front Cell Dev Biol. 2021;9:775462. doi:10.3389/fcell.2021.775462
   PubMed Web of Science ®Google Scholar
• Kaps L, Schuppan D. Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers. Cells. 2020;9(9):2027. doi:10.3390/cells9092027
   PubMed Web of Science ®Google Scholar
• Du D, Liu C, Qin M, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharmaceutica Sinica B. 2022;12(2):558–580. doi:10.1016/j.apsb.2021.09.019
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang W, Zhou Q, et al. Roles of circRNAs in the tumour microenvironment. Mol Cancer. 2020;19(1):14. doi:10.1186/s12943-019-1125-9
   PubMed Web of Science ®Google Scholar
• Shi M, Li Z-Y, Zhang L-M, et al. Hsa_circ_0007456 regulates the natural killer cell-mediated cytotoxicity toward hepatocellular carcinoma via the miR-6852-3p/ICAM-1 axis. Cell Death Dis. 2021;12(1):94. doi:10.1038/s41419-020-03334-8
   PubMed Web of Science ®Google Scholar
• Zhang PF, Gao C, Huang X-Y, et al. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer. 2020;19(1):110. doi:10.1186/s12943-020-01222-5
   PubMed Web of Science ®Google Scholar
• Hu Z, Chen G, Zhao Y, et al. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22(1):55. doi:10.1186/s12943-023-01759-1
   PubMed Web of Science ®Google Scholar
• Huang M, Huang X, Huang N. Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells. Cancer Sci. 2022;113(6):1968–1983. doi:10.1111/cas.15365
   PubMed Web of Science ®Google Scholar
• Li Q, Pan X, Zhu D, et al. Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p/PKM2 axis under hypoxic stress. Hepatology. 2019;70(4):1298–1316. doi:10.1002/hep.30671
   PubMed Web of Science ®Google Scholar
• Wang X, Sheng W, Xu T, et al. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARalpha/CCL2 pathway. Aging. 2021;13(8):11969–11987. doi:10.18632/aging.202900
   PubMedGoogle Scholar
• Cao P, Ma B, Sun D, et al. hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR-139-3p/CCL5 axis. Cancer Sci. 2022;113(2):634–647. doi:10.1111/cas.15238
   PubMed Web of Science ®Google Scholar
• Li J, Hu Z-Q, Yu S-Y, et al. CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma. Cancer Res. 2022;82(6):1055–1069. doi:10.1158/0008-5472.CAN-21-1259
   PubMed Web of Science ®Google Scholar
• Ying F, Chan M, Lee T. Cancer-associated fibroblasts in hepatocellular carcinoma and cholangiocarcinoma. Cell Mol Gastroenterol Hepatol. 2023;15(4):985–999. doi:10.1016/j.jcmgh.2023.01.006
   PubMed Web of Science ®Google Scholar
• Liu G, Sun J, Yang Z-F, et al. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death Dis. 2021;12(3):260. doi:10.1038/s41419-021-03545-7
   PubMed Web of Science ®Google Scholar
• Lu JC, Zhang P-F, Huang X-Y, et al. Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma. J Hematol Oncol. 2021;14(1):200. doi:10.1186/s13045-021-01207-x
   PubMed Web of Science ®Google Scholar
• Wang Y, Stancliffe E, Fowle-Grider R, et al. Saturation of the mitochondrial NADH shuttles drives aerobic glycolysis in proliferating cells. Molecular Cell. 2022;82(17):3270–3283.e9. doi:10.1016/j.molcel.2022.07.007
   PubMed Web of Science ®Google Scholar
• Sun XH, Wang Y-T, Li G-F, et al. Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma. Cancer Cell Int. 2020;20(1):226. doi:10.1186/s12935-020-01302-y
   PubMed Web of Science ®Google Scholar
• Tsilimigras DI, Bagante F, Sahara K, et al. Prognosis after resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification. Ann Surg Oncol. 2019;26(11):3693–3700. doi:10.1245/s10434-019-07580-9
   PubMed Web of Science ®Google Scholar
• Park JW, Chen M, Colombo M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35(9):2155–2166. doi:10.1111/liv.12818
   PubMed Web of Science ®Google Scholar
• Wei Y, Chen X, Liang C, et al. A noncoding regulatory RNAs network driven by Circ-CDYL acts specifically in the early stages hepatocellular carcinoma. Hepatology. 2020;71(1):130–147. doi:10.1002/hep.30795
   PubMed Web of Science ®Google Scholar
• Song R, Ma S, Xu J, et al. A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR. Mol Cancer. 2023;22(1):16. doi:10.1186/s12943-023-01719-9
   PubMed Web of Science ®Google Scholar
• Liu R, Li Y, Wu A, et al. Identification of Plasma hsa_circ_0005397 and combined with serum AFP, AFP-L3 as potential biomarkers for hepatocellular carcinoma. Front Pharmacol. 2021;12:639963. doi:10.3389/fphar.2021.639963
   PubMed Web of Science ®Google Scholar
• Li X, Yang J, Yang X, et al. Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma. J Clin Lab Anal. 2021;35(6):e23785. doi:10.1002/jcla.23785
   PubMed Web of Science ®Google Scholar
• Chen G, Xie D, Zhang P, et al. Circular RNA hsa_circ_0000437 may be used as a new indicator for the diagnosis and prognosis of hepatocellular carcinoma. Bioengineered. 2022;13(6):14118–14124. doi:10.1080/21655979.2022.2081458
   PubMed Web of Science ®Google Scholar
• Zhang PF, Wei C-Y, Huang X-Y, et al. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression. Mol Cancer. 2019;18(1):105. doi:10.1186/s12943-019-1031-1
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang W, Zhu G, Xie J, Chen X. Rethinking cancer nanotheranostics. Nat Rev Mater. 2017;2:1–8.
   Web of Science ®Google Scholar
• Wang J, Chen P, Dong Y, et al. Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy. Biomaterials. 2021;276:121056. doi:10.1016/j.biomaterials.2021.121056
   PubMed Web of Science ®Google Scholar
• Grigoryeva ES, Savelieva OE, Popova NO, et al. Do tumor exosome integrins alone determine organotropic metastasis? Mol Biol Rep. 2020;47(10):8145–8157. doi:10.1007/s11033-020-05826-4
   PubMed Web of Science ®Google Scholar
• He AT, Liu J, Li F, et al. Targeting circular RNAs as a therapeutic approach: current strategies and challenges. Signal Transduct Target Ther. 2021;6(1):185. doi:10.1038/s41392-021-00569-5
   PubMed Web of Science ®Google Scholar
• Chen YG, Chen R, Ahmad S, et al. N6-methyladenosine modification controls circular RNA immunity. Molecular Cell. 2019;76(1):96–109.e9. doi:10.1016/j.molcel.2019.07.016
   PubMed Web of Science ®Google Scholar
• Zhao J, Lee EE, Kim J, et al. Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus. Nat Commun. 2019;10(1):2300. doi:10.1038/s41467-019-10246-5
   PubMedGoogle Scholar
• Chen Y, Tian Z. HBV-Induced Immune Imbalance in the Development of HCC. Front Immunol. 2019;10:2048. doi:10.3389/fimmu.2019.02048
   PubMed Web of Science ®Google Scholar
• Rao X, Lai L, Li X, et al. N6-methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305. IUBMB Life. 2021;73(2):408–417. doi:10.1002/iub.2438
   PubMed Web of Science ®Google Scholar
• Chen YG, Kim MV, Chen X, et al. Sensing self and foreign circular RNAs by intron identity. Molecular Cell. 2017;67(2):228–238.e5. doi:10.1016/j.molcel.2017.05.022
   PubMed Web of Science ®Google Scholar
• Liu CX, Guo S-K, Nan F, et al. RNA circles with minimized immunogenicity as potent PKR inhibitors. Mol Cell. 2022;82(2):420–434.e6. doi:10.1016/j.molcel.2021.11.019
   PubMed Web of Science ®Google Scholar
• Boucherit N, Gorvel L, Olive D. 3D tumor models and their use for the testing of immunotherapies. Front Immunol. 2020;11:603640. doi:10.3389/fimmu.2020.603640
   PubMed Web of Science ®Google Scholar
• Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020;13(1):4–16. doi:10.1186/s13045-019-0829-z
   PubMed Web of Science ®Google Scholar
• Xu F, Wu S, Yi L, et al. Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques. Emerg Microbes Infect. 2022;11(1):438–441. doi:10.1080/22221751.2022.2030199
   PubMed Web of Science ®Google Scholar
• Zuo L, Zhang L, Zu J, et al. Circulating circular RNAs as biomarkers for the diagnosis and prediction of outcomes in acute ischemic stroke. Stroke. 2020;51(1):319–323. doi:10.1161/STROKEAHA.119.027348
   PubMed Web of Science ®Google Scholar